Cargando…
Probiotics combined with rifaximin influence the neurometabolic changes in a rat model of type C HE
Type C hepatic encephalopathy (HE) is a neuropsychiatric disease caused by chronic liver disease. Management of type C HE remains an important challenge because treatment options are limited. Both the antibiotic rifaximin and probiotics have been reported to reduce the symptoms of HE, but longitudin...
Autores principales: | Flatt, Emmanuelle, McLin, Valérie A., Braissant, Olivier, Pierzchala, Katarzyna, Mastromarino, Paola, Mitrea, Stefanita-Octavian, Sessa, Dario, Gruetter, Rolf, Cudalbu, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429411/ https://www.ncbi.nlm.nih.gov/pubmed/34504135 http://dx.doi.org/10.1038/s41598-021-97018-8 |
Ejemplares similares
-
Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease
por: Rackayová, Veronika, et al.
Publicado: (2021) -
Longitudinal osmotic and neurometabolic changes in young rats with chronic cholestatic liver disease
por: Rackayova, Veronika, et al.
Publicado: (2020) -
Neurometabolic changes in a rat pup model of type C hepatic encephalopathy depend on age at liver disease onset
por: Simicic, Dunja, et al.
Publicado: (2023) -
The C57BL/6J Mouse Exhibits Sporadic Congenital Portosystemic Shunts
por: Cudalbu, Cristina, et al.
Publicado: (2013) -
An Approach to Neurometabolic Epilepsy in Children with an Underlying Neurometabolic Disorder
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2020)